Founded in Janesville, Wisconsin, SHINE Technologies (formerly SHINE Medical Technologies) focuses on producing radioactive isotopes for medical applications. The company's core mission is to redefine what's possible in the fields of medical isotope production, nuclear waste recycling, and fusion energy generation. Their flagship product, Ilumira n.c.a. lutetium, is shipped weekly for medical use. SHINE aims to commercialize fusion technology through a phased approach, enhancing core competencies and delivering valuable products to the market.
SHINE Technologies has attracted notable investors and industry leaders, contributing to its rapid growth and innovation. The company has achieved significant milestones, including the successful commercialization of fusion technology and the consistent production of medical isotopes. SHINE's impact extends beyond healthcare, as it also focuses on inspecting industrial components and recycling nuclear waste, positioning itself as a leader in sustainable nuclear technology.
Nuclear Medicine Isotopes is SHINE Technologies' medical isotope line supplying non-carrier-added Lutetium-177, TechneLite Tc-99m generators, and Molybdenum-99 for radiopharmaceutical production.
